World J Diabetes. 2015 Jun 10;6(5):744-51. doi: 10.4239/wjd.v6.i5.744.
Emerging links between type 2 diabetes and Alzheimer's disease.
World journal of diabetes
Gumpeny R Sridhar, Gumpeny Lakshmi, Gumpeny Nagamani
Affiliations
Affiliations
- Gumpeny R Sridhar, Gumpeny Lakshmi, Gumpeny Nagamani, Endocrine and Diabetes Centre, Department of Obstetrics and Gynecology, Andhra Medical College, Visakhapatnam 530002, India.
PMID: 26069723
PMCID: PMC4458503 DOI: 10.4239/wjd.v6.i5.744
Abstract
Type 2 diabetes mellitus and Alzheimer's disease are both associated with increasing age, and each increases the risk of development of the other. Epidemiological, clinical, biochemical and imaging studies have shown that elevated glucose levels and diabetes are associated with cognitive dysfunction, the most prevalent cause of which is Alzheimer's disease. Cross sectional studies have clearly shown such an association, whereas longitudinal studies are equivocal, reflecting the many complex ways in which the two interact. Despite the dichotomy, common risk and etiological factors (obesity, dyslipidemia, insulin resistance, and sedentary habits) are recognized; correction of these by lifestyle changes and pharmacological agents can be expected to prevent or retard the progression of both diseases. Common pathogenic factors in both conditions span a broad sweep including chronic hyperglycemia per se, hyperinsulinemia, insulin resistance, acute hypoglycemic episodes, especially in the elderly, microvascular disease, fibrillar deposits (in brain in Alzheimer's disease and in pancreas in type 2 diabetes), altered insulin processing, inflammation, obesity, dyslipidemia, altered levels of insulin like growth factor and occurrence of variant forms of the protein butyrylcholinesterase. Of interest not only do lifestyle measures have a protective effect against the development of cognitive impairment due to Alzheimer's disease, but so do some of the pharmacological agents used in the treatment of diabetes such as insulin (especially when delivered intranasally), metformin, peroxisome proliferator-activated receptors γ agonists, glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes must be recognized as a risk for development of Alzheimer's disease; clinicians must ensure preventive care be given to control and postpone both conditions, and to identify cognitive impairment early to manage it appropriately.
Keywords: Butyrylcholinesterase; Cognition; Dementia; Insulin; Insulin resistance
References
- Diabetologia. 2011 Dec;54(12):3022-7 - PubMed
- Am J Geriatr Psychiatry. 2003 Mar-Apr;11(2):131-45 - PubMed
- J Cell Mol Med. 2011 Aug;15(8):1747-56 - PubMed
- JAMA Neurol. 2013 Sep 1;70(9):1167-72 - PubMed
- Med Hypotheses. 2010 Dec;75(6):648-51 - PubMed
- Eur J Pharmacol. 2004 Apr 19;490(1-3):5-12 - PubMed
- Lipids Health Dis. 2006 Nov 11;5:28 - PubMed
- Diabetes. 1999 Oct;48(10):1915-21 - PubMed
- Clin Chim Acta. 2007 Mar;378(1-2):128-35 - PubMed
- Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8628-33 - PubMed
- Br J Clin Pharmacol. 2011 Mar;71(3):365-76 - PubMed
- N Engl J Med. 2013 Aug 8;369(6):540-8 - PubMed
- Diabetes Care. 2014 Nov;37(11):3076-83 - PubMed
- Neuron. 1996 Apr;16(4):881-91 - PubMed
- Neurology. 1995 Jun;45(6):1161-8 - PubMed
- Lancet. 2012 Jun 16;379(9833):2291-9 - PubMed
- Amyloid. 2007 Jun;14(2):119-31 - PubMed
- Diabetes. 1999 Mar;48(3):557-63 - PubMed
- Brain Res Dev Brain Res. 1991 Oct 21;62(2):293-6 - PubMed
- Age Ageing. 2008 Jul;37(4):458-61 - PubMed
- Curr Alzheimer Res. 2008 Oct;5(5):438-47 - PubMed
- Diabetes Care. 2013 Oct;36(10):2981-7 - PubMed
- Hum Mol Genet. 1997 Oct;6(11):1933-6 - PubMed
- Science. 2014 May 16;344(6185):687-9 - PubMed
- Neurology. 2010 Aug 31;75(9):764-70 - PubMed
- J Clin Invest. 2012 Apr;122(4):1191 - PubMed
- Indian J Endocrinol Metab. 2012 Dec;16(Suppl 3):S601-10 - PubMed
- Diabetes Care. 2004 May;27(5):1047-53 - PubMed
- Diabetes. 2010 Nov;59(11):2883-9 - PubMed
- J Diabetes Investig. 2012 Oct 18;3(5):413-23 - PubMed
- Diabetes. 2014 Dec;63(12):3992-7 - PubMed
- JAMA. 2009 Apr 15;301(15):1565-72 - PubMed
- Diabetes. 2014 Feb;63(2):663-74 - PubMed
- Lipids Health Dis. 2005 Sep 08;4:18 - PubMed
- N Engl J Med. 2007 May 3;356(18):1842-52 - PubMed
- Neurosci Lett. 1990 Jul 31;115(2-3):279-85 - PubMed
- J Assoc Physicians India. 2010 May;58:290-4 - PubMed
- J Clin Endocrinol Metab. 2012 Feb;97(2):366-76 - PubMed
- Diabetes Care. 2010 Oct;33(10 ):2169-74 - PubMed
- Med Hypotheses. 2007;69(6):1272-6 - PubMed
- Front Endocrinol (Lausanne). 2014 Jul 08;5:110 - PubMed
- J Alzheimers Dis. 2014;42 Suppl 4:S515-23 - PubMed
- Science. 2009 Nov 13;326(5955):1005-7 - PubMed
- Am J Epidemiol. 1997 Feb 15;145(4):301-8 - PubMed
- Diabetes Care. 2009 Feb;32(2):221-6 - PubMed
- Diabetologia. 2004 Aug;47(8):1437-41 - PubMed
- J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):917-22 - PubMed
- Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3907-12 - PubMed
- PLoS One. 2014 Jul 02;9(7):e100778 - PubMed
- Dement Geriatr Cogn Disord. 2010;30(5):381-6 - PubMed
- Neurology. 1999 Dec 10;53(9):1937-42 - PubMed
- Neurology. 2011 Sep 20;77(12):1126-34 - PubMed
- Bratisl Lek Listy. 2013;114(12):726-34 - PubMed
- Physiol Behav. 1991 Feb;49(2):335-8 - PubMed
Publication Types